These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6190040)

  • 1. An HPLC method for the simultaneous quantitation of quinidine, procainamide, N-acetylprocainamide, and disopyramide.
    Bridges RR; Jennison TA
    J Anal Toxicol; 1983; 7(2):65-8. PubMed ID: 6190040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
    Wesley JF; Lasky FD
    Clin Biochem; 1981 Jun; 14(3):113-8. PubMed ID: 6170476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of lidocaine, mexiletine, disopyramide, and quinidine in plasma by high performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Anal Toxicol; 1985; 9(2):67-70. PubMed ID: 3990250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.
    Lai CM; Kamath BL; Look ZM; Yacobi A
    J Pharm Sci; 1980 Aug; 69(8):982-4. PubMed ID: 6157019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantitation of quinidine, procainamide, and N-acetylprocainamide in serum by gas-liquid chromatography with a nitrogen-phosphorus selective detector.
    Kessler KM; Ho-Tung P; Steele B; Silver J; Pickoff A; Narayanan S; Myerburg RJ
    Clin Chem; 1982 May; 28(5):1187-90. PubMed ID: 6176367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide.
    Roden DM; Woosley RL
    Pharmacol Ther; 1983; 23(2):179-91. PubMed ID: 6199801
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous analysis of antiarrhythmic drugs and metabolites by high performance liquid chromatography: interference studies and comparisons with other methods.
    Wesley JF; Lasky FD
    Clin Biochem; 1982 Dec; 15(6):284-90. PubMed ID: 6762929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
    Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
    J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY; Benowitz NL
    Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs.
    Lagerström PO; Persson BA
    J Chromatogr; 1978 Feb; 149():331-40. PubMed ID: 649734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the TDX fluorescence polarization immunoassays for procainamide and n-acetylprocainamide.
    Sonsalla PK; Bridges RR; Jennison TA; Smith CM
    J Anal Toxicol; 1985; 9(4):152-5. PubMed ID: 2412001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous liquid-chromatographic determination of five antiarrhythmic drugs and their major active metabolites in serum.
    Proelss HF; Townsend TB
    Clin Chem; 1986 Jul; 32(7):1311-7. PubMed ID: 3087659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.
    Dutcher JS; Strong JM
    Clin Chem; 1977 Jul; 23(7):1318-20. PubMed ID: 872378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct determination of procainamide and N-acetylprocainamide by capillary zone electrophoresis in pharmaceutical formulations and urine.
    Vargas G; Havel J; Hadasová E
    J Chromatogr A; 1997 Jun; 772(1-2):271-6. PubMed ID: 9226929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring disopyramide, lidocaine, and quinidine by micellar liquid chromatography.
    Ochoa-Aranda E; Esteve-Romero J; Rambla-Alegre M; Martinavarro-Domínguez A; Bose D
    J AOAC Int; 2011; 94(2):537-42. PubMed ID: 21563688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous liquid-chromatographic determination of three antiarrhythmic drugs: disopyramide, lidocaine, and quinidine.
    Flood JG; Bowers GN; McComb RB
    Clin Chem; 1980 Feb; 26(2):197-200. PubMed ID: 6986211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug monitoring.
    Howanitz JH; Howanitz PJ
    Clin Lab Med; 1981 Sep; 1(3):501-22. PubMed ID: 6179688
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.